Maarten van der Doelen
Chapter 2
Supplementary table 3. Outcomes of EORTC QLQ-C30 and EORTC QLQ-BM22 questionnaires.
Follow-up 12 months (n=5)
Follow-up 18 months (n=3)
Baseline (n=7)
End of therapy (n=7)
EORTC QLQ-C30 questionnaire Functional scales a Physical
67 [53-80]
73 [60-100]
87 [30-93]
67 NA
Role
33 [33-67]
50 [33-100]
83 [8-100]
67 NA
Emotional
75 [42-75]
75 [67-100]
83 [67-92]
83 NA
Cognitive
100 [50-100]
100 [67-100]
83 [58-100]
100 NA
Social
83 [50-100]
67 [33-100]
83 [33-100]
50 NA
Symptom scales and items b Fatigue
56 [33-67]
33 [22-78]
22 [17-83]
56 NA
Nausea and vomiting
17 [0-50]
0 [0-17]
0 [0-33]
0 NA
Pain
50 [50-67]
17 [0-33]
17 [0-92]
17 NA
Dyspnoea
67 [33-67]
33 [0-33]
0 [0-50]
33 NA
Insomnia
33 [33-100]
33 [0-100]
0 [0-67]
33 NA
Appetite loss
33 [0-100]
0 [0-67]
0 [0-50]
33 NA
Constipation
0 [0-67]
0 [0-67]
33 [0-67]
0 NA
Diarrhea
0 [0-33]
0 [0-0]
0 [0-0]
33 NA
Financial difficulties
0 [0-0]
0 [0-0]
0 [0-50]
0 NA
58 [50-83]
75 [33-83]
75 [42-88]
58 NA
Global health status c
EORTC QLQ-BM22 questionnaire Symptom scales Painful sites b
27 [20-40]
7 [0-27]
7 [0-27]
7 NA
Pain characteristics b
22 [22-33]
11 [0-22]
22 [0-50]
11 NA
Functional scales
75 [50-88]
96 [83-100]
96 [65-98]
83 NA
Functional interference a
Psychosocial aspects b 67 NA Data are presented as median scores [IQR]. EORTC = European Organization for Research and Treatment of Cancer; NA = not applicable; QLQ-BM22 = Quality of Life Questionnaire-Bone Metastases 22; QLQ-C30 = Quality of Life Questionnaire-Core 30. a Higher scores indicate better functioning. b Higher scores indicate worse symptoms/aspects. c Higher scores indicate higher quality of life. 56 [50-67] 50 [39-61] 72 [50-83]
48
Made with FlippingBook - professional solution for displaying marketing and sales documents online